PHARMADEV is a Swiss company with an affiliate PHARMADEV Healthcare-Ireland Ltd for EU.
Founded in 2007 PHARMADEV develops generic patented plus products to improve their tolerance and efficacy but focus on few products for a better knowledge of their potential.
PHARMADEV owns Marketing Authorizations for Ribavirin, antiviral indicated in Human hepatis C and hemorrhagic fevers with patented process formulation to improve compliance, PHARMADEV holds Marketing Authorizations for fast acting derivative of Ibuprofen in France, Germany and Italy, with a patented process for OTC antalgic market.
Processed products are available for licensing.